Detailed answers about THE BEATSON ONCOLOGY CENTRE FUND, including incorporation, status, business activity, and accounts information.
When was THE BEATSON ONCOLOGY CENTRE FUND founded?
THE BEATSON ONCOLOGY CENTRE FUND was officially incorporated on 11 April 2011 and is registered under company number SC397449. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE BEATSON ONCOLOGY CENTRE FUND?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of THE BEATSON ONCOLOGY CENTRE FUND?
THE BEATSON ONCOLOGY CENTRE FUND's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE BEATSON ONCOLOGY CENTRE FUND do?
THE BEATSON ONCOLOGY CENTRE FUND operates in the following sector: 74990 - Non-trading company. This provides insight into the company's primary business activity and industry focus.
What is THE BEATSON ONCOLOGY CENTRE FUND's registered address?
The registered office address of THE BEATSON ONCOLOGY CENTRE FUND is 1 GEORGE SQUARE, GLASGOW, SCOTLAND, G2 1AL. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE BEATSON ONCOLOGY CENTRE FUND financially stable?
The most recent accounts for THE BEATSON ONCOLOGY CENTRE FUND were made up to 31 March 2025, filed as DORMANT. Next accounts are due by 31 December 2026.